- Home
- JANX vs KLC Comparison
JANX vs KLC Comparison
Compare JANX & KLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- KLC
- Stock Information
- Founded
- JANX 2017
- KLC 1969
- Country
- JANX United States
- KLC United States
- Employees
- JANX N/A
- KLC N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- KLC
- Sector
- JANX Health Care
- KLC
- Exchange
- JANX Nasdaq
- KLC NYSE
- Market Cap
- JANX 1.6B
- KLC 1.3B
- IPO Year
- JANX 2021
- KLC 2024
- Fundamental
- Price
- JANX $31.05
- KLC $12.07
- Analyst Decision
- JANX Strong Buy
- KLC Buy
- Analyst Count
- JANX 7
- KLC 8
- Target Price
- JANX $94.29
- KLC $27.88
- AVG Volume (30 Days)
- JANX 975.8K
- KLC 900.4K
- Earning Date
- JANX 05-06-2025
- KLC 05-14-2025
- Dividend Yield
- JANX N/A
- KLC N/A
- EPS Growth
- JANX N/A
- KLC N/A
- EPS
- JANX N/A
- KLC N/A
- Revenue
- JANX $10,588,000.00
- KLC $2,663,035,000.00
- Revenue This Year
- JANX N/A
- KLC $6.50
- Revenue Next Year
- JANX $250.58
- KLC $4.90
- P/E Ratio
- JANX N/A
- KLC N/A
- Revenue Growth
- JANX 30.99
- KLC 6.09
- 52 Week Low
- JANX $22.52
- KLC $10.31
- 52 Week High
- JANX $71.71
- KLC $29.89
- Technical
- Relative Strength Index (RSI)
- JANX 55.36
- KLC N/A
- Support Level
- JANX $27.93
- KLC N/A
- Resistance Level
- JANX $32.59
- KLC N/A
- Average True Range (ATR)
- JANX 1.97
- KLC 0.00
- MACD
- JANX 0.74
- KLC 0.00
- Stochastic Oscillator
- JANX 84.75
- KLC 0.00
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About KLC KINDERCARE LEARNING COMPANIES INC
KinderCare Learning Companies Inc is a private provider of early childhood education and care services (ECE) in the United States. It serves children ranging from 6 weeks to 12 years of age across its market footprint of around 1,480 early childhood education centers with a capacity of more than 194,000 children and contracts for more than 650 before- and after-school sites located in 40 states and the District of Columbia. Its segment derives revenue from providing early childhood education and care services at centers and before- and after-school sites.